Furthermore, immunohistochemistry showed that the expression levels of BCL‐2 and MCL‐1, two major cell apoptosis‐related molecules, were decreased by vandetanib in K562 tumor tissues (Fig. 5J). Here, MCL1 is linked to neoplasm.